Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | HPGDS | O60760 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12181924 | 0.89 | ALDH1A1 (0.46) | ALDH1A1F2GLAHPGDMEN1 | |
| SCHEMBL3739279 | 0.85 | ALDH1A1 (0.37) | ALDH1A1F2GLAHPGDMEN1 | |
| SCHEMBL12182074 | 0.84 | ALDH1A1 (0.37) | ALDH1A1F2GLAHPGDMEN1 | |
| SCHEMBL2220295 | 0.81 | ALDH1A1 (0.44) | ALDH1A1F2GLAHPGDKMT2A | |
| SCHEMBL2221877 | 0.79 | ALDH1A1 (0.45) | ALDH1A1F2GLAHPGDKMT2A | |
| SCHEMBL3730532 | 0.77 | ALDH1A1 (0.36) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL12181918 | 0.77 | ALDH1A1 (0.45) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL3732277 | 0.76 | HPGDS (0.39) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL2222087 | 0.76 | ALDH1A1 (0.40) | ALDH1A1F2GLAHPGDHPGDS | |
| SCHEMBL12181920 | 0.75 | ALDH1A1 (0.45) | ALDH1A1F2GLAHPGDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120283216-A1 | FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY | 2012-11-08 | — | — | US | disclosed |
| EP-2516385-A2 | FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES | E. I. du Pont de Nemours and Company (US) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011087837-A2 | FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120283216-A1 | FUNGICIDAL 2-(BICYCLIC ARYLOXY)CARBOXAMIDES | CBR3, CBR1, Q6ZSR9 | ALDH1A1 1771/4885F2 2650/4885GLA 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.